Engineered neuromuscular actuators for medicine, meat, and machines
Author(s)
Raman, Ritu
Download43577_2021_122_ReferencePDF.pdf (317.8Kb)
Publisher Policy
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Abstract
Movement is central to life. Neuromuscular tissues control voluntary movement in humans and many other living creatures, offering significant advantages in adaptability and robustness as compared to abiotic actuators. The impressive functional capabilities of neuromuscular tissues have inspired researchers to attempt de novo synthesis of the biological motor system via tissue engineering. This article highlights key recent advances in tissue engineering skeletal muscle and discusses promising strategies to control engineered muscle via biological neural networks and abiotic soft electronic interfaces. Challenges associated with cell sourcing, biomaterials design, and scalable precision manufacturing, along with emerging strategies to address those challenges, are presented. Finally, we highlight how engineered neuromuscular tissues have enabled studying, controlling, and deploying them as actuators in a range of real-world applications including drug discovery, regenerative medicine, cellular agriculture, and soft robotics.
Graphic abstract
Date issued
2021-06Department
Koch Institute for Integrative Cancer Research at MITJournal
MRS Bulletin
Publisher
Springer International Publishing
ISSN
1938-1425
0883-7694